The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...

Pharmaceuticals announced that the U.S. FDA has approved Revuforj as the first and only menin inhibitor for the treatment of ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

The Democrat faced backlash after saying he’s “excited” about Trump nominating the conspiracy theorist to lead the Department of Health and Human Services.

The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...

The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...

Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...

Colorado Gov. Jared Polis (D) is facing backlash following a comment he made about being “excited” by President-elect tapping ...